跳到正文

Lappe Mark 内部人交易:近期 SEC Form 4 交易

过去 18 个月,Lappe Mark(CIK 1366074)在 1 家公司共报告 16 笔 SEC Form 4 内部人交易(最近一笔 2026-10-14)。

日期公司身份类型股数市值
2026-10-14Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入2,470$207,655
2026-10-14Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入2,470$209,948
2026-10-14Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入100$8,576
2026-10-14Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入2,449$205,889
2026-10-14Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入2,451$208,333
2026-10-14Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入100$8,576
2026-09-28Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入3,324$328,644
2026-09-28Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入2,176$216,730
2026-09-28Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入1,500$148,320
2026-09-28Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入3,000$305,100
2026-09-08Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入5,895$585,315
2026-09-08Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入6,605$664,727
2026-09-08Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入1,100$117,832
2026-09-08Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入500$54,120
2026-09-08Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入1,219$136,382
2026-09-08Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer买入9,681$1.1M

来源:SEC Form 4 申报文件 · 截至 2026-10-14